Literature DB >> 15522434

Impact of intrinsic DNA structure on processing of plasmids for gene therapy and DNA vaccines.

James R Cooke1, Elizabeth A McKie, John M Ward, Eli Keshavarz-Moore.   

Abstract

Several non-Watson Crick DNA structures have been discovered to date, which may be incorporated into future plasmid constructs for gene therapy and DNA vaccine products. In this study, intrinsic DNA structures were included at a defined point in a 2.9 kb plasmid, and their effects on cell growth rate, total plasmid yield, and topology (i.e. the relative proportions of supercoiled plasmid, open circular and linear forms), were determined. The stability of the inserted sequences were assessed using gel electrophoresis. Z-DNA was shown to be unstable in a batch Escherichia coli DH1 production system grown in complex medium. Encouragingly other sequences studied (triplex, bend and quadruplex) did not cause spontaneous deletions, and no detrimental effect was found on growth rate or on total plasmid yield; indicating that such sequences could be included in future DNA products without any detrimental effect on plasmid yields; although the intra molecular triplex studied significantly decreased the proportion of supercoiled species.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522434     DOI: 10.1016/j.jbiotec.2004.06.011

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  8 in total

1.  Vector insert-targeted integrative antisense expression system for plasmid stabilization.

Authors:  Jeremy M Luke; Aaron E Carnes; Clague P Hodgson; James A Williams
Journal:  Mol Biotechnol       Date:  2011-01       Impact factor: 2.695

Review 2.  Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA.

Authors:  Juergen Mairhofer; Reingard Grabherr
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

Review 3.  Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

Authors:  James A Williams; Aaron E Carnes; Clague P Hodgson
Journal:  Biotechnol Adv       Date:  2009-02-20       Impact factor: 14.227

4.  Serious overestimation in quantitative PCR by circular (supercoiled) plasmid standard: microalgal pcna as the model gene.

Authors:  Yubo Hou; Huan Zhang; Lilibeth Miranda; Senjie Lin
Journal:  PLoS One       Date:  2010-03-05       Impact factor: 3.240

5.  Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes.

Authors:  James A Williams; Jeremy Luke; Sarah Langtry; Sheryl Anderson; Clague P Hodgson; Aaron E Carnes
Journal:  Biotechnol Bioeng       Date:  2009-08-15       Impact factor: 4.530

6.  Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode.

Authors:  Gheorghe M Borja; Eugenio Meza Mora; Blanca Barrón; Guillermo Gosset; Octavio T Ramírez; Alvaro R Lara
Journal:  Microb Cell Fact       Date:  2012-09-19       Impact factor: 5.328

Review 7.  The Five Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy.

Authors:  Suneetha Amara; Venkataswarup Tiriveedhi
Journal:  Int J Mol Sci       Date:  2017-03-17       Impact factor: 5.923

Review 8.  Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic.

Authors:  Mike Hoare; M Susana Levy; Daniel G Bracewell; Steven D Doig; Simyee Kong; Nigel Titchener-Hooker; John M Ward; Peter Dunnill
Journal:  Biotechnol Prog       Date:  2005 Nov-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.